Histogen Inc. (HSTOQ)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Aug 1, 2025, 4:00 PM EDT
Altus Power Revenue
Histogen had revenue of $5.00K in the quarter ending September 30, 2023. This brings the company's revenue in the last twelve months to $19.00K, down -99.50% year-over-year. In the year 2022, Histogen had annual revenue of $3.77M with 265.21% growth.
Revenue (ttm)
19.00K
Revenue Growth
-99.50%
P/S Ratio
0.07
Revenue / Employee
2.71K
Employees
7
Market Cap
1.28K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 3.77M | 2.74M | 265.21% |
Dec 31, 2021 | 1.03M | -1.03M | -49.88% |
Dec 31, 2020 | 2.06M | -9.40M | -82.02% |
Dec 31, 2019 | 11.45M | 9.68M | 544.57% |
Dec 31, 2018 | 1.78M | -7.87M | -81.58% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |